Pegavision Corporation (TPE:6491)
Taiwan · Delayed Price · Currency is TWD 284.50
-6.50 (-2.23%)
At close: Feb 11, 2026
Pegavision Revenue
In the year 2025, Pegavision had annual revenue of 7.04B TWD with 3.26% growth. Pegavision had revenue of 1.93B in the quarter ending December 31, 2025, with 7.56% growth.
Revenue
7.04B
Revenue Growth
+3.26%
P/S Ratio
3.15
Revenue / Employee
n/a
Employees
n/a
Market Cap
22.19B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 7.04B | 222.10M | 3.26% |
| Dec 31, 2024 | 6.82B | 27.44M | 0.40% |
| Dec 31, 2023 | 6.79B | 468.66M | 7.41% |
| Dec 31, 2022 | 6.32B | 726.16M | 12.98% |
| Dec 31, 2021 | 5.60B | 1.62B | 40.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| St.Shine Optical | 4.40B |
| Visco Vision | 4.07B |
| Formosa Optical Technology | 3.98B |
| Vizionfocus | 3.30B |
| Pacific Hospital Supply | 2.47B |
| Nang Kuang Pharmaceutical | 2.22B |
| Bioteque | 2.07B |
| Bionime | 1.91B |